Abridged Applications
Course
In The Rembrandt Hotel, London
Description
-
Type
Course
-
Level
Intermediate
-
Location
The rembrandt hotel, london
-
Class hours
8h
-
Duration
1 Day
This seminar is concerned with the current aspects of abridged applications and will include information on any new issues arising in relation to these applications.
Safety, quality and efficacy will be addressed in an integrated fashion and the importance of application registration planning will be stressed.
A basic knowledge of the application procedure will be assumed
Facilities
Location
Start date
Start date
About this course
TOPICS TO BE COVERED
The legislation associated with Abridged Applications
Paediatrics and Abridged Applications
Bioequivalence, BCS Classifications and Biowaiver
Clinical Issues and SmPC
Pharmaceutical and Quality Issues
Drug substance data, European drug master files and CEPs
Managing Directors
Research and Development Directors
Medical Directors
Clinical Research Managers and Clinical Pharmacologists
Research and Development and Registration Managers
Quality Assurance Managers
New recruits to registration
Regulatory and CMC Managers
New Recruits to Registration
A basic knowedge of the application procedure will be assumed.
Reviews
Subjects
- Quality
- Quality Training
- Abridged
- Management
- Life Science
- Pharma
- Pharmaceutical Marketing
- Regulations
- EU Law
- Training
Teachers and trainers (2)
Dr Anmar Marouf
Scientific Director at Inresa Arzneimittel GmbH, Freiburg, Germany.
Dr Patrick Salmon
Irish Medicines Board
Course programme
09.00 Registration & Coffee
09.30 Introduction and the legislation associated with Abridged applications
- The Current legislation: Directive 2001/83 as amended
- The Mutual Recognition and Decentralised procedures
- Centralised Procedures
- Paediatrics and Abridged Applications
- Problem areas with generic applications
Dr Patrick Salmon
10.15 Bioequivalence – Studies
- When are they needed?
- BCS classification and Biowaiver
- Reference and test product
- Common problems and how to avoid them
Dr Patrick Salmon
11.15 Refreshments
11.30 Pharmaceutical Quality Issues – 1
- Drug substance data
- Certificates of suitability (CEP)
- European drug master files (EDMF/ASMF)
- Pharmaceutical development for abridged products
Dr Anmar Marouf
12.45 Discussion
13.00 Lunch
14.00 Case Studies
15.15 Refreshments
15.30 Clinical Issues and SmPC
- Review of data requirements: full versus abridged
- Line extension
- Bibliographical/Well Established Use
- Generic products
- Risk Management Plans
- Biosimilars
- Modified Release, Fixed Combination, Topical products
Dr Patrick Salmon
16.30 Pharmaceutical Quality Issues – 2
- Manufacture and control of drug products
- Manufacture process validation
- Analytical Methodology and Validation
- Stability testing of drug substance and drug products
Dr Anmar Marouf
17.30 End of Day
Abridged Applications